Medications

In search of clues to fight antibiotic resistance

To combat the rise of drug-resistant bacteria, researchers are examining how one superbug adapts to fight an antibiotic of last resort, hoping to find clues that can prolong the drug's effectiveness.

Diseases, Conditions, Syndromes

Hospital cleaning trial cuts infections

A major trial of a bundle of hospital cleaning practices in 11 Australian hospitals has made significant reductions in healthcare associated infections and demonstrated cost-benefits.

Diseases, Conditions, Syndromes

Vancomycin + piperacillin / tazobactam ups kidney risk

(HealthDay)—For hospitalized children, coadministration of intravenous (IV) vancomycin and piperacillin/tazobactam is associated with increased risk of acute kidney injury (AKI), according to a study published online Oct. ...

Diseases, Conditions, Syndromes

Fecal microbiota transplant cost-effective for preventing CDI

(HealthDay)—Use of fecal microbiota transplantation (FMT) is cost-effective for recurrent Clostridium difficile infection (CDI), according to a study published in the December issue of the Journal of Gastroenterology and ...

Diseases, Conditions, Syndromes

Pharmacists' study helps prevent antibiotic-induced kidney failure

When associate professor of pharmacy practice Tadd Hellwig and three pharmacy colleagues at the Sanford USD Medical Center noticed that some hospital patients given two common antibiotics developed kidney failure, they decided ...

page 1 from 6

Vancomycin

Vancomycin (INN) (pronounced /ˌvæŋkɵˈmaɪsɪn/) is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. It has traditionally been reserved as a drug of "last resort", used only after treatment with other antibiotics had failed, although the emergence of vancomycin-resistant organisms means that it is increasingly being displaced from this role by linezolid and daptomycin.

This text uses material from Wikipedia, licensed under CC BY-SA